Quest Partners LLC Ionis Pharmaceuticals Inc Transaction History
Quest Partners LLC
- $737 Billion
- Q2 2024
A detailed history of Quest Partners LLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Quest Partners LLC holds 1,373 shares of IONS stock, worth $52,050. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,373
Previous 2,297
40.23%
Holding current value
$52,050
Previous $99.6 Million
34.28%
% of portfolio
0.01%
Previous 0.02%
Shares
3 transactions
Others Institutions Holding IONS
# of Institutions
395Shares Held
125MCall Options Held
2.25MPut Options Held
510K-
Vanguard Group Inc Valley Forge, PA13.8MShares$525 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD12.6MShares$479 Million0.38% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$391 Million0.01% of portfolio
-
Bellevue Group Ag Kuesnacht, V88.26MShares$313 Million6.59% of portfolio
-
Wellington Management Group LLP Boston, MA6.57MShares$249 Million0.06% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $5.38B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...